ABVC BioPharma is an early-stage biotechnology company developing a pipeline of seven new drugs and one medical device, all licensed from related parties. Its pipeline targets CNS disorders (major depressive disorder, ADHD) and oncology/hematology (lung cancer, pancreatic cancer, cancer-related depression). Revenue comes from outlicensing intellectual properties and CDMO services via its subsidiary BioKey, which also manufactures maitake mushroom dietary supplements.
expected 2026-11-26
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-03 | 2025-12-31 | 0001213900-26-023063 | EDGAR | 100K words |
| 2025-04-15 | 2024-12-31 | 0001213900-25-032118 | EDGAR | 100K words |
| 2024-03-13 | 2023-12-31 | 0001213900-24-022235 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0001213900-23-025554 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001213900-22-016726 | EDGAR | — |
| 2021-03-16 | 2020-12-31 | 0001213900-21-015729 | EDGAR | — |
| 2020-05-15 | 2019-12-31 | 0001213900-20-012685 | EDGAR | — |
| 2019-04-15 | 2018-12-31 | 0001213900-19-006364 | EDGAR | — |
| 2018-01-16 | 2017-09-30 | 0001213900-18-000537 | EDGAR | — |
| 2017-01-12 | 2016-09-30 | 0001213900-17-000304 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-12 | 2026-06-30 | 0001213900-26-088348 | EDGAR | 44K words |
| 2025-11-03 | 2025-09-30 | 0001213900-25-104811 | EDGAR | 54K words |
| 2025-08-13 | 2025-06-30 | 0001213900-25-075644 | EDGAR | 52K words |
| 2025-04-30 | 2025-03-31 | 0001213900-25-037676 | EDGAR | 47K words |
| 2024-11-14 | 2024-09-30 | 0001213900-24-097840 | EDGAR | 47K words |
| 2024-08-14 | 2024-06-30 | 0001213900-24-068907 | EDGAR | — |
| 2024-05-17 | 2024-03-31 | 0001213900-24-044731 | EDGAR | 51K words |
| 2023-11-15 | 2023-09-30 | 0001213900-23-087270 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001213900-23-067113 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001213900-23-039733 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001213900-22-072317 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001213900-22-048113 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-27 | 0001213900-26-094152 | EDGAR | 10K words |
| 2026-08-04 | 0001213900-26-084846 | EDGAR | 1K words |
| 2026-03-27 | 0001213900-26-035499 | EDGAR | 1K words |
| 2026-03-03 | 0001213900-26-023054 | EDGAR | 1K words |
| 2025-11-03 | 0001213900-25-104900 | EDGAR | 1K words |
| 2025-10-30 | 0001213900-25-103799 | EDGAR | 1K words |
| 2025-08-14 | 0001213900-25-076018 | EDGAR | 1K words |
| 2025-06-04 | 0001213900-25-051144 | EDGAR | 1K words |
| 2025-05-01 | 0001213900-25-038060 | EDGAR | 1K words |
| 2025-04-30 | 0001213900-25-037654 | EDGAR | 4K words |
450 total filings indexed. 418 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001173313 |
| Ticker | ABVC |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NV |
| Website | https://www.abvcpharma.com |
| Listed | 2004-11-09 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ABVC (~200 tokens, structured JSON with cryptographic provenance)